|Bid||75.15 x 100|
|Ask||75.16 x 100|
|Day's Range||74.65 - 75.99|
|52 Week Range||63.76 - 82.10|
|PE Ratio (TTM)||7.96|
|Dividend & Yield||2.08 (2.82%)|
|1y Target Est||N/A|
The Fed will be overshadowed on Wednesday by the continued parade of corporate earnings coming out this week.
Shares of Gilead Sciences (GILD) are on the rise this morning after the biotech giant reported better-than expected earnings and revenue, and raised its product-sales guidance. Gilead reported a profit of $2.56 a share, beating forecasts for $2.29, on sales of $$7.1 billion, topping analyst expectations for $6.3 billion. Gilead also said that its net product sales would come in between $24.5 billion and 25.5 billion in 2017, up from a range of $22.5 billion to $24.5 billion.
These are the stocks posting the largest moves before the bell.